Results 81 to 90 of about 10,174 (135)

[Review of clinical practice guidelines for hypoparathyroidism]. [PDF]

Probl Endokrinol (Mosk), 2021
Kovaleva EV, Eremkina AK, Krupinova JA, Mirnaya SS, Kim IV, Kuznetzov NS, Andreeva EN, Karonova TL, Kryukova IV, Mudunov AM, Sleptcov IV, Melnichenko GA, Mokrysheva NG, Dedov II.   +13 more
europepmc   +1 more source

Teasing Apart the Effect of Depression Specific and Anxiety Specific Symptoms on Academic Outcomes. [PDF]

Klin Spec Psihol, 2020
Gorman EL, Burke HH, Rubino LG, Vargas I, Haeffel GJ.   +4 more
europepmc   +1 more source

Plasma Neurotrophic Factor Levels are not Associated with the Severity of Depression: Prospective Pilot Study. [PDF]

Consort Psychiatr, 2021
Zorkina YA, Syunyakov TS, Abramova OV, Yunes RA, Pavlichenko AV, Pavlov KA, Khobta EB, Susloparova DA, Tsarapkin GY, Andreyuk DS, Danilenko VN, Gurina OI, Morozova AY.   +12 more
europepmc   +1 more source

Znachimost' trevozhno-depressivnykh rasstroystv dlya godovogo i dolgosrochnogo prognoza pri infarkte miokarda v zavisimosti ot nalichiya sakharnogo diabeta tipa 2

КардиоСоматика, 2013
Тревожно-депрессивные расстройства – независимые предикторы неблагоприятного прогноза при инфаркте миокарда, однако их роль при сопутствующем сахарном диабете типа 2 изучена недостаточно. Цель исследования. Оценка клинической и прогностической значимости
Nataliya Yur'evna Ardashova, Nataliya Borisovna Lebedeva, Svetlana Aleksandrovna Pomeshkina, Ol'ga Leonidovna Barbarash   +3 more
doaj  

[Features of the use of synthetic analogues of thyroid hormones: а 2020 THESIS* questionnaire survey of members of the Belarusian Public Medical Association of Endocrinology and Metabolism]. [PDF]

Probl Endokrinol (Mosk), 2021
Shepelkevich AP, Dydyshka YV, Yurenya EV, Lоbashova VL, Attanasio R, Hegedüs L, Nagy E, Negro R, Papini E, Perros P.   +9 more
europepmc   +1 more source

Comparative pharmacoeconomical analysis of modern antidepressants in monotherapy

Качественная клиническая практика, 2018
Compare the cost effectiveness and budget impact of vortioxetine in monotherapy of depressive disorders with several other important antidepressants using pharmacoeconomic methods within context of Russian healthcare.
A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov   +2 more
doaj  

Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression. [PDF]

Consort Psychiatr, 2022
Reznik A, Syunyakov T, Akhmerova I, Butylin D, Vasilenko A, Gvozdetckii A, Gizatullin T, Gilmanshina G, Golosov E, Kolchev S, Linova L, Miron D, Mudrak A, Oleichik I, Sizov S, Tarakanova E, Chesnokova O.   +16 more
europepmc   +1 more source

Individual chronotype as a predictor of treatment effectiveness

Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
A study was conducted on depressive patients (n = 100, F.31-33, mean age 48 ±16 yrs) to identify factors for improve treatment effectiveness, clinical and chronobiological characteristics were evaluated.
M. Yu. Gerasimchuk
doaj  

Self-destruction in the formation of addictive and neurotic disorders: suicidal and risk-taking behaviour

Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
This paper considers two forms of self-destructive behaviour in groups of young highly educated patients with dependencies (F1) and neurotic disorders (F4). The prevalence of suicidal ideation was 25.5% and risk-taking behaviour 18.2%. These symptoms are
N. A. Bokhan, I. V. Voevodin
doaj  

How to treat addicted patient with concomitant psychiatric diagnosis?

Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
Alcohol use disorders often co-occur with affective disorders, anxiety disorders and schizophrenia. The presence of dual diagnosis worsens the prognosis in patients.
A. Y. Egorov, F. Sh. Shagiahmetov
doaj